UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway

Annals of oncology, 2010-02, Vol.21 (2), p.263-268

2010

Volltextzugriff (PDF)

Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease

Annals of oncology, 2017-09, Vol.28 (9), p.2199-2205

2017

Volltextzugriff (PDF)

EML4-ALK fusion variants associate with gender and age in Chinese NSCLC patients

Annals of oncology, 2018-10, Vol.29, p.viii43-viii43

2018

Volltextzugriff (PDF)

Prospective validation of prognostic scores to improve patient selection for immuno-oncology trials

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii144

2018

Volltextzugriff (PDF)

1242MO The addition of belomethason propionate inhalation to radical radiotherapy for patients with locally advanced non-small cell lung cancer: A randomized controlled, open-label phase II study

Annals of oncology, 2024-09, Vol.35, p.S795-S795

2024

Volltextzugriff (PDF)

831P Decitabine sensitized TP53-mutated diffuse large B cell lymphoma to R-CHOP treatment via activation of endogenous retrovirus

Annals of oncology, 2023-10, Vol.34, p.S546-S546

2023

Volltextzugriff (PDF)

1432P Efficacy and safety of large-field postoperative radiotherapy using 3D radiation technique for locally advanced thoracic esophageal squamous cell carcinoma: A phase II clinical trial

Annals of oncology, 2020-09, Vol.31, p.S904-S904

2020

Volltextzugriff (PDF)

861P Neo-TIME trial: Neoadjuvant tislelizumab combined with albumin-paclitaxel, cisplatin, and fluorouracil(APF) in patients with locally advanced oral squamous cell carcinoma (LA-OSCC)

Annals of oncology, 2024-09, Vol.35, p.S620-S620

2024

Volltextzugriff (PDF)

Detection and clinicopathologic features of ctDNA in T790M-positive advanced lung adenocarcinomas patients after failure of treatment with first- and second-generation EGFR-TKIs

Annals of oncology, 2019-04, Vol.30, p.ii52-ii52

2019

Volltextzugriff (PDF)

819P Efficacy and safety of orelabrutinib plus R-CHOP-like regimens for treatment-naïve diffuse large B-cell lymphoma with double expression

Annals of oncology, 2024-09, Vol.35, p.S603-S604

2024

Volltextzugriff (PDF)

879P Targeted next-generation sequencing reveals CDKN2A alterations as a prognostic biomarker in recurrent or metastatic head and neck squamous cell carcinoma mostly treated with immune checkpoint inhibitors

Annals of oncology, 2023-10, Vol.34, p.S565-S566

2023

Volltextzugriff (PDF)

224P Lung cancer scRNA-seq analyses reveal potential mechanisms causing different efficacy of target therapy and immunotherapy between EGFR 19del and L858R lung adenocarcinoma

Annals of oncology, 2024-09, Vol.35, p.S305-S305

2024

Volltextzugriff (PDF)

Identification of novel and known FGFR gene fusions in Chinese non-small cell lung cancer

Annals of oncology, 2019-10, Vol.30, p.v798-v799

2019

Volltextzugriff (PDF)

1988P - Identification of novel and known FGFR gene fusions in Chinese non-small cell lung cancer

Annals of oncology, 2019-10, Vol.30, p.v798-v799

2019

Volltextzugriff (PDF)

CN83Symptom cluster of fatigue, sleep disturbance and depression and its impact on quality of life among Chinese breast cancer patients undergoing adjuvant chemotherapy: A cross-sectional study

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

373P Safety and efficacy of aumolertinib treatment in patients with advanced NSCLC harboring uncommon EGFR mutations: Cohort 2

Annals of oncology, 2022-11, Vol.33, p.S1587-S1588

2022

Volltextzugriff (PDF)

1988PIdentification of novel and known FGFR gene fusions in Chinese non-small cell lung cancer

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

271P First-in-human, phase I dose escalation and expansion study of anti-HER2 ADC MRG002 in patients with HER2 positive solid tumors

Annals of oncology, 2021-09, Vol.32, p.S480-S481

2021

Volltextzugriff (PDF)

22MO Efficacy and safety of sacituzumab govitecan in Chinese patients with metastatic triple-negative breast cancer (mTNBC) by baseline HER2 expression level: Subgroup analysis from a phase IIb trial

Annals of oncology, 2022-11, Vol.33, p.S1438-S1438

2022

Volltextzugriff (PDF)

Symptom cluster of fatigue, sleep disturbance and depression and its impact on quality of life among Chinese breast cancer patients undergoing adjuvant chemotherapy: A cross-sectional study

Annals of oncology, 2019-10, Vol.30, p.v840

2019

Volltextzugriff (PDF)

CN83 - Symptom cluster of fatigue, sleep disturbance and depression and its impact on quality of life among Chinese breast cancer patients undergoing adjuvant chemotherapy: A cross-sectional study

Annals of oncology, 2019-10, Vol.30, p.v840-v840

2019

Volltextzugriff (PDF)

248P Sacituzumab govitecan in Chinese patients with metastatic triple-negative breast cancer who received at least two prior treatments

Annals of oncology, 2022-09, Vol.33, p.S650

2022

Volltextzugriff (PDF)

555P TQB2450 injection combined with anlotinib hydrochloride capsule in the treatment of advanced, recurrent or metastatic endometrial cancer: A multicohort, open label, multicenter phase II clinical trial - The TQB2450-II-08 trial

Annals of oncology, 2022-09, Vol.33, p.S802

2022

Volltextzugriff (PDF)

1397P Prevalence, molecular characterization, and prognosis of MET–overexpressing non-small cell lung cancer (NSCLC) in a real-world patient cohort

Annals of oncology, 2023-10, Vol.34, p.S799-S800

2023

Volltextzugriff (PDF)

Systematic inflammatory response markers (SIRs) factors associated with pain prevalence and other characteristics in advanced cancer patients

Annals of oncology, 2017-11, Vol.28, p.x144-x144

2017

Volltextzugriff (PDF)

1 – 25 von 328

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAnnals Of Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(328)
Mit Volltextzugriff
(328)

Publikationsform

Artikel
(328)

Sprache

Englisch
(328)

Erscheinungsjahr

n.n

Thema

Humans
(28)
Life Sciences & Biomedicine
(28)
Oncology
(28)
Science & Technology
(28)
Female
(18)
Male
(15)
Middle Aged
(15)
Adult
(12)
Antineoplastic Agents
(12)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Pharmacology. Drug Treatments
(12)
Aged
(11)
Tumors
(11)
Aged, 80 And Over
(6)
Multiple Tumors. Solid Tumors. Tumors In Childhood
(6)
Mutation
(6)
Prospective Studies
(6)
Young Adult
(6)
Biomarkers, Tumor - Genetics
(5)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Neu hinzugefügt

... seit 90 Tagen
(40)

Menü

Weitere Dienste

Einstellungen

Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway

Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease

EML4-ALK fusion variants associate with gender and age in Chinese NSCLC patients

Prospective validation of prognostic scores to improve patient selection for immuno-oncology trials

1242MO The addition of belomethason propionate inhalation to radical radiotherapy for patients with locally advanced non-small cell lung cancer: A randomized controlled, open-label phase II study

831P Decitabine sensitized TP53-mutated diffuse large B cell lymphoma to R-CHOP treatment via activation of endogenous retrovirus

1432P Efficacy and safety of large-field postoperative radiotherapy using 3D radiation technique for locally advanced thoracic esophageal squamous cell carcinoma: A phase II clinical trial

861P Neo-TIME trial: Neoadjuvant tislelizumab combined with albumin-paclitaxel, cisplatin, and fluorouracil(APF) in patients with locally advanced oral squamous cell carcinoma (LA-OSCC)

Detection and clinicopathologic features of ctDNA in T790M-positive advanced lung adenocarcinomas patients after failure of treatment with first- and second-generation EGFR-TKIs

819P Efficacy and safety of orelabrutinib plus R-CHOP-like regimens for treatment-naïve diffuse large B-cell lymphoma with double expression

879P Targeted next-generation sequencing reveals CDKN2A alterations as a prognostic biomarker in recurrent or metastatic head and neck squamous cell carcinoma mostly treated with immune checkpoint inhibitors

224P Lung cancer scRNA-seq analyses reveal potential mechanisms causing different efficacy of target therapy and immunotherapy between EGFR 19del and L858R lung adenocarcinoma

Identification of novel and known FGFR gene fusions in Chinese non-small cell lung cancer

1988P - Identification of novel and known FGFR gene fusions in Chinese non-small cell lung cancer

CN83Symptom cluster of fatigue, sleep disturbance and depression and its impact on quality of life among Chinese breast cancer patients undergoing adjuvant chemotherapy: A cross-sectional study

373P Safety and efficacy of aumolertinib treatment in patients with advanced NSCLC harboring uncommon EGFR mutations: Cohort 2

1988PIdentification of novel and known FGFR gene fusions in Chinese non-small cell lung cancer

271P First-in-human, phase I dose escalation and expansion study of anti-HER2 ADC MRG002 in patients with HER2 positive solid tumors

22MO Efficacy and safety of sacituzumab govitecan in Chinese patients with metastatic triple-negative breast cancer (mTNBC) by baseline HER2 expression level: Subgroup analysis from a phase IIb trial

Symptom cluster of fatigue, sleep disturbance and depression and its impact on quality of life among Chinese breast cancer patients undergoing adjuvant chemotherapy: A cross-sectional study

CN83 - Symptom cluster of fatigue, sleep disturbance and depression and its impact on quality of life among Chinese breast cancer patients undergoing adjuvant chemotherapy: A cross-sectional study

248P Sacituzumab govitecan in Chinese patients with metastatic triple-negative breast cancer who received at least two prior treatments

555P TQB2450 injection combined with anlotinib hydrochloride capsule in the treatment of advanced, recurrent or metastatic endometrial cancer: A multicohort, open label, multicenter phase II clinical trial - The TQB2450-II-08 trial

1397P Prevalence, molecular characterization, and prognosis of MET–overexpressing non-small cell lung cancer (NSCLC) in a real-world patient cohort

Systematic inflammatory response markers (SIRs) factors associated with pain prevalence and other characteristics in advanced cancer patients

Aktive Filter

Suchergebnisse filtern